Pharma News

According to the CDE website on December 25, Boehringer Ingelheim’s (BI) oral HER2 inhibitor Zongertinib tablets (BI 1810631) have been proposed for inclusion in the priority review process. The drug is intended for treating unresectable or metastatic HER

On December 20, China’s National Healthcare Security Administration (NHSA) issued an official letter to provincial and regional healthcare bureaus, requiring an investigation into ginkgo leaf extract injection, cefotaxime sodium injection, and hydrolyzed

Oral medications are increasingly favored by long-term treatment patients due to their convenience. Current oral medications include PDE4 inhibitor apremilast, TYK2 allosteric inhibitor deucravacitinib, and JAK inhibitor upadacitinib. Moreover, numerous m

Recently, Novo Nordisk announced the efficacy and safety data from its semaglutide and Cagrilintide combination therapy in the weight loss domain from the Phase III clinical trial REDEFINE 1.

On December 18, Eli Lilly announced that its donanemab injection has been approved by the National Medical Products Administration of China for the treatment of mild cognitive impairment and mild dementia caused by Alzheimer’s Disease (AD).

On December 20, Jinxing Pharmaceuticals and Sanofi officially announced a collaboration agreement, granting Sanofi exclusive rights to develop and commercialize aficamten in the Greater China region. The transaction is expected to be completed within 2024

In recent years, the rapid expansion of Danish pharmaceutical giant Novo Nordisk has not only driven national economic growth but also sparked intense labor competition. As of September this year, Novo Nordisk has reached approximately 32,000 employees in

Recently, AstraZeneca announced that the FDA has rejected its application for full approval of the drug Andexxa. Andexxa was submitted for market approval in China in December 2022. Initially, it received accelerated approval from the FDA in 2018 and cond

On December 18, Eli Lilly announced that its developed Donanemab injection has received approval from the drug regulatory authority and is officially on the market. This medication is approved for treating adults with mild cognitive impairment and mild de

Merck & Co. (MSD) announced today that the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA), aimed at protecting infants during their first respiratory syncytial virus (RSV) season from RSV disease. The applicat

The journal Nature Reviews Drug Discovery recently published a predictive analysis of the top 10 best-selling drugs globally in 2025. Pembrolizumab, commonly known as "K Drug," is expected to become the leading drug for the year, followed closely by semag

Under the current conditions of limited resources, from the perspective of maximizing national life expectancy, some policies that may seem detrimental to industrial development are, in fact, reasonable. Recently, the "soul-cutting" approach of centralize

Pfizer Inc. announced on Tuesday that despite the nomination of Robert F. Kennedy Jr., a vaccine skeptic, by newly elected President Trump for the position of Secretary of the Department of Health and Human Services, the company expects no significant cha

In recent years, pharmaceutical companies have increasingly relied on external contractors for drug testing and production. Novo Nordisk's parent company, Novo Holdings, announced the acquisition of major contract manufacturer Catalent for $16.5 billion,

Nestlé's Chief Technology Officer Stefan Palzer told Reuters, “By increasing natural GLP-1 levels, it helps control hunger, thereby significantly impacting satiety.” On Amazon, the product is priced at $10.99 for a box of four, and it is available at sele

Once the bonds are delisted, the remaining funds will be transferred out of the account to permanently supplement working capital. Previously, the main fundraising projects for these bonds included Phase I and Phase II of modern pharmaceutical preparation

On December 13, McKinsey signed the agreement in the Federal Court of Virginia, stipulating that if McKinsey pays $650 million and meets a series of conditions over the next five years—such as refraining from providing sales, marketing, and promotion serv

In the 10th round of national centralized drug procurement, the extremely low price of enteric-coated aspirin tablets has garnered widespread attention. Specifically, the price was as low as RMB 0.03 per tablet.

On December 16, Innovent Biologics and Eli Lilly announced a collaboration agreement for the non-covalent (reversible) Bruton’s tyrosine kinase (BTK) inhibitor, pirtobrutinib, in mainland China.

In the current global pharmaceutical market, gene therapy drugs occupy a significant portion of the most expensive drug rankings, with five listed in the top ten. Pfizer's recently approved treatment for moderate to severe Hemophilia B, Beqvez, is priced